In susceptible mice, Leishmania major induce very rapid interleukin-4 production by CD4(+) T cells which are NK1.1(-)

被引:157
作者
Launois, P
Ohteki, T
Swihart, K
MacDonald, HR
Louis, JA
机构
[1] UNIV LAUSANNE,INST BIOCHEM,WHO,IRTC,CH-1066 EPALINGES,SWITZERLAND
[2] UNIV LAUSANNE,LUDWIG INST CANC RES,LAUSANNE BRANCH,CH-1066 EPALINGES,SWITZERLAND
关键词
Leishmania major; interleukin-4; NK1.1(-) CD4(+) T cells;
D O I
10.1002/eji.1830251215
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Susceptibility of BALB/c mice to infection with Leishmania major is associated with a T helper type 2 (Th2) response. Since interleukin-4 (IL-4) is critically required early for Th2 cell development, the kinetics of IL-4 mRNA expression was compared in susceptible and resistant mice during the first days of infection. In contrast to resistant mice, susceptible mice exhibited a peak of IL-4 mRNA in their spleens 90 min after i.v. injection of parasites and in lymph nodes 16 h after s.c. injection. IL-12 and interferon-gamma (IFN-gamma) down-regulated this early peak of IL-4 mRNA; the effect of IL-12 was IFN-gamma dependent. Treatment of resistant C57BL/6 mice with anti-IFN-gamma allowed the expression of this early IL-4 response to L. major. The increased IL-4 mRNA expression occurred in V beta 8, 7, 2(-) CD4(+) cells in BALB/c mice and NK1.1(-) CD4(+) cells in anti-IFN-gamma treated C57BL/6 mice. These results show that the NK1.1(+) CD4(+) cells, responsible for the rapid burst of IL-4 production after i.v. injection of anti-CD3, do not contribute to the early IL-4 response to L. major.
引用
收藏
页码:3298 / 3307
页数:10
相关论文
共 61 条
[41]  
ROCKEN M, 1992, J IMMUNOL, V148, P1031
[42]  
SADICK MD, 1987, J IMMUNOL, V139, P1303
[43]   CURE OF MURINE LEISHMANIASIS WITH ANTI-INTERLEUKIN-4 MONOCLONAL-ANTIBODY - EVIDENCE FOR A T-CELL DEPENDENT, INTERFERON-GAMMA INDEPENDENT MECHANISM [J].
SADICK, MD ;
HEINZEL, FP ;
HOLADAY, BJ ;
PU, RT ;
DAWKINS, RS ;
LOCKSLEY, RM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1990, 171 (01) :115-127
[44]  
SCHARTONKERSTEN T, 1995, J IMMUNOL, V154, P5320
[45]  
SCOTT P, 1991, J IMMUNOL, V147, P3149
[46]   THE PRESENCE OF INTERLEUKIN-4 DURING INVITRO PRIMING DETERMINES THE LYMPHOKINE-PRODUCING POTENTIAL OF CD4+ T-CELLS FROM T-CELL RECEPTOR TRANSGENIC MICE [J].
SEDER, RA ;
PAUL, WE ;
DAVIS, MM ;
FAZEKAS DE ST GROTH, B .
JOURNAL OF EXPERIMENTAL MEDICINE, 1992, 176 (04) :1091-1098
[47]   INTERLEUKIN-12 ACTS DIRECTLY ON CD4+ T-CELLS TO ENHANCE PRIMING FOR INTERFERON-GAMMA PRODUCTION AND DIMINISHES INTERLEUKIN-4 INHIBITION OF SUCH PRIMING [J].
SEDER, RA ;
GAZZINELLI, R ;
SHER, A ;
PAUL, WE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (21) :10188-10192
[48]  
STAERZ UD, 1985, J IMMUNOL, V134, P3994
[49]  
SWAIN SL, 1990, J IMMUNOL, V144, P1788
[50]   MICE FROM A GENETICALLY RESISTANT BACKGROUND LACKING THE INTERFERON-GAMMA RECEPTOR ARE SUSCEPTIBLE TO INFECTION WITH LEISHMANIA-MAJOR BUT MOUNT A POLARIZED T-HELPER CELL 1-TYPE CD4(+) T-CELL RESPONSE [J].
SWIHART, K ;
FRUTH, U ;
MESSMER, N ;
HUG, K ;
BEHIN, R ;
HUANG, S ;
DELGIUDICE, G ;
AGUET, M ;
LOUIS, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (03) :961-971